Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125045) titled 'Clinical Comprehensive Evaluation of Drugs for the Treatment of Methicillin-Resistant Staphylococci' on May 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shandong Provincial Hospital
Condition:
infection
Intervention:
Vancomycin/Norvancomycin group:None
Linezolid group:None
Teicoplanin group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-01-02
Target Sample Size: Vancomycin/Norvancomycin group:300;Linezolid group:300;Teicoplanin group:300;Daptomycin group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.o...